GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » EV-to-EBITDA

SLS BIO Co (XKRX:246250) EV-to-EBITDA : 18.16 (As of May. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SLS BIO Co's enterprise value is ₩29,802 Mil. SLS BIO Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,641 Mil. Therefore, SLS BIO Co's EV-to-EBITDA for today is 18.16.

The historical rank and industry rank for SLS BIO Co's EV-to-EBITDA or its related term are showing as below:

XKRX:246250' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.97   Med: 15.37   Max: 26.27
Current: 18.17

During the past 9 years, the highest EV-to-EBITDA of SLS BIO Co was 26.27. The lowest was 11.97. And the median was 15.37.

XKRX:246250's EV-to-EBITDA is ranked worse than
58.41% of 113 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.37 vs XKRX:246250: 18.17

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), SLS BIO Co's stock price is ₩4810.00. SLS BIO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩77.415. Therefore, SLS BIO Co's PE Ratio for today is 62.13.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


SLS BIO Co EV-to-EBITDA Historical Data

The historical data trend for SLS BIO Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co EV-to-EBITDA Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 26.96 147.45 35.32 9.31 13.28

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial 9.31 - - 13.28 23.85

Competitive Comparison of SLS BIO Co's EV-to-EBITDA

For the Diagnostics & Research subindustry, SLS BIO Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's EV-to-EBITDA falls into.



SLS BIO Co EV-to-EBITDA Calculation

SLS BIO Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=29801.523/1640.812
=18.16

SLS BIO Co's current Enterprise Value is ₩29,802 Mil.
SLS BIO Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,641 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co  (XKRX:246250) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

SLS BIO Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4810.00/77.415
=62.13

SLS BIO Co's share price for today is ₩4810.00.
SLS BIO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩77.415.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


SLS BIO Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines